{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:03:34Z","timestamp":1784034214183,"version":"3.55.0"},"reference-count":77,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,5,18]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Central venous access device (CVAD)-related thrombosis (CRT) is a common complication among patients requiring central venous access as part of their medical care. Complications of CRT include pulmonary embolism, recurrent deep venous thrombosis, loss of central venous access, and postthrombotic syndrome. Patient-, device-, and treatment-related factors can influence the risk of CRT. Despite numerous randomized controlled trials, the clinical benefit of pharmacologic thromboprophylaxis for the prevention of CRT remains to be established. Therefore, minimizing patient exposure to known risk factors is the best available approach to prevent CRT. Venous duplex is recommended for the diagnosis of CRT. Anticoagulation for at least 3 months or the duration of the indwelling CVAD is recommended for treatment of CRT. Thrombolysis should be considered for patients at low risk for bleeding who have limb-threatening thrombosis or whose symptoms fail to resolve with adequate anticoagulation. CVAD removal should be consider for patients with bacteremia, persistent symptoms despite anticoagulation, and if the CVAD is no longer needed. Superior vena cava filters should be avoided. Prospective studies are needed to define the optimal management of patients with or at risk for CRT.<\/jats:p>","DOI":"10.1182\/blood-2016-08-693671","type":"journal-article","created":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T00:53:03Z","timestamp":1491267183000},"page":"2727-2736","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":78,"title":["How I treat central venous access device\u2013related upper extremity deep vein thrombosis"],"prefix":"10.1182","volume":"129","author":[{"given":"Anita","family":"Rajasekhar","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, University of Florida, Gainesville, FL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Streiff","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine and"},{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"9684","key":"2019111902535688400_B1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0140-6736(09)60220-8","article-title":"Management of occlusion and thrombosis associated with long-term indwelling central venous catheters","volume":"374","author":"Baskin","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"2019111902535688400_B2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1378\/chest.07-1432","article-title":"Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry","volume":"133","author":"Mu\u00f1oz","year":"2008","journal-title":"Chest"},{"issue":"4","key":"2019111902535688400_B3","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1378\/chest.10-0154","article-title":"Risk of symptomatic DVT associated with peripherally inserted central catheters","volume":"138","author":"Evans","year":"2010","journal-title":"Chest"},{"issue":"12","key":"2019111902535688400_B4","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/01.CIR.0000142289.94369.D7","article-title":"Upper-extremity deep vein thrombosis: a prospective registry of 592 patients","volume":"110","author":"Joffe","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"2019111902535688400_B5","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/jth.13131","article-title":"Central venous catheters and upper extremity deep vein thrombosis in medical inpatients: the Medical Inpatients and Thrombosis (MITH) Study","volume":"13","author":"Winters","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019111902535688400_B6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1538574411432145","article-title":"The risk factors and clinical outcomes of upper extremity deep vein thrombosis","volume":"46","author":"Lee","year":"2012","journal-title":"Vasc Endovascular Surg"},{"issue":"5","key":"2019111902535688400_B7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1024\/0301-1526\/a000217","article-title":"Risk factors, management and primary prevention of thrombotic complications related to the use of central venous catheters","volume":"41","author":"Linnemann","year":"2012","journal-title":"Vasa"},{"issue":"9","key":"2019111902535688400_B8","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1200\/JCO.2005.03.5600","article-title":"Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111902535688400_B9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11739-008-0125-3","article-title":"Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients","volume":"3","author":"Verso","year":"2008","journal-title":"Intern Emerg Med"},{"issue":"3","key":"2019111902535688400_B10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2141.1986.tb07541.x","article-title":"Central venous thrombosis due to bolus injections of antileukaemic chemotherapy","volume":"63","author":"Baglin","year":"1986","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111902535688400_B11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/TA.0b013e31827a0b2f","article-title":"Which central venous catheters have the highest rate of catheter-associated deep venous thrombosis: a prospective analysis of 2,128 catheter days in the surgical intensive care unit","volume":"74","author":"Malinoski","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"2019111902535688400_B12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1378\/chest.10-2637","article-title":"The effect of catheter to vein ratio on blood flow rates in a simulated model of peripherally inserted central venous catheters","volume":"140","author":"Nifong","year":"2011","journal-title":"Chest"},{"issue":"9","key":"2019111902535688400_B13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMcp1008740","article-title":"Clinical practice. Deep-vein thrombosis of the upper extremities","volume":"364","author":"Kucher","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111902535688400_B14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5301\/jva.5000039","article-title":"Risk factors for upper extremity venous thrombosis associated with peripherally inserted central venous catheters","volume":"13","author":"Marnejon","year":"2012","journal-title":"J Vasc Access"},{"issue":"6","key":"2019111902535688400_B15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3322\/CA.2008.0015","article-title":"Vascular access in oncology patients","volume":"58","author":"Gallieni","year":"2008","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2019111902535688400_B16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/01.CIR.0000137123.55051.9B","article-title":"Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities","volume":"110","author":"Martinelli","year":"2004","journal-title":"Circulation"},{"issue":"13","key":"2019111902535688400_B17","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMoa1500964","article-title":"Intravascular Complications of Central Venous Catheterization by Insertion Site","volume":"373","author":"Parienti","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111902535688400_B18","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jama.286.6.700","article-title":"Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial","volume":"286","author":"Merrer","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"2019111902535688400_B19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1378\/chest.114.1.207","article-title":"Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis","volume":"114","author":"Timsit","year":"1998","journal-title":"Chest"},{"issue":"2","key":"2019111902535688400_B20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1538-7836.2010.04126.x","article-title":"Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies","volume":"9","author":"Saber","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"9889","key":"2019111902535688400_B21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(13)60592-9","article-title":"Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis","volume":"382","author":"Chopra","year":"2013","journal-title":"Lancet"},{"issue":"5","key":"2019111902535688400_B22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.thromres.2015.02.012","article-title":"Patterns, risk factors and treatment associated with PICC-DVT in hospitalized adults: A nested case-control study","volume":"135","author":"Chopra","year":"2015","journal-title":"Thromb Res"},{"issue":"3","key":"2019111902535688400_B23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1148\/radiol.2203001181","article-title":"Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US","volume":"220","author":"Luciani","year":"2001","journal-title":"Radiology"},{"issue":"3","key":"2019111902535688400_B24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2141.2003.04638.x","article-title":"Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound","volume":"123","author":"van Rooden","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111902535688400_B25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11239-015-1175-9","article-title":"A systematic review of patient-related risk factors for catheter-related thrombosis","volume":"40","author":"Leung","year":"2015","journal-title":"J Thromb Thrombolysis"},{"issue":"12","key":"2019111902535688400_B26","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1200\/JCO.2005.05.002","article-title":"Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study","volume":"23","author":"van Rooden","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111902535688400_B27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1538-7836.2007.02823.x","article-title":"Association between inherited thrombophilic abnormalities and central venous catheter thrombosis in patients with cancer: a meta-analysis","volume":"6","author":"Dentali","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111902535688400_B28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/asheducation-2014.1.306","article-title":"Central venous catheter-related thrombosis","volume":"2014","author":"Geerts","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"2019111902535688400_B29","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.thromres.2015.08.020","article-title":"Systematic review of anticoagulant treatment of catheter-related thrombosis","volume":"136","author":"Baumann Kreuziger","year":"2015","journal-title":"Thromb Res"},{"issue":"6","key":"2019111902535688400_B30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-76-3-112-6-423","article-title":"Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial","volume":"112","author":"Bern","year":"1990","journal-title":"Ann Intern Med"},{"issue":"2","key":"2019111902535688400_B31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0038-1650254","article-title":"Upper extremity deep venous thrombosis in cancer patients with venous access devices--prophylaxis with a low molecular weight heparin (Fragmin)","volume":"75","author":"Monreal","year":"1996","journal-title":"Thromb Haemost"},{"issue":"3","key":"2019111902535688400_B32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1365-2141.1998.00732.x","article-title":"Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies","volume":"101","author":"Boraks","year":"1998","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111902535688400_B33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2257.1999.00250.x","article-title":"Thrombosis, markers of thrombotic risk, indwelling central venous catheters and antithrombotic prophylaxis using low-dose warfarin in subjects with malignant disease","volume":"21","author":"Ratcliffe","year":"1999","journal-title":"Clin Lab Haematol"},{"issue":"3","key":"2019111902535688400_B34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1445-5994.2002.00171.x","article-title":"Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis","volume":"32","author":"Heaton","year":"2002","journal-title":"Intern Med J"},{"issue":"1","key":"2019111902535688400_B35","first-page":"67","article-title":"Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial","volume":"88","author":"Mismetti","year":"2003","journal-title":"Haematologica"},{"issue":"18","key":"2019111902535688400_B36","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1200\/JCO.2005.06.084","article-title":"Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients","volume":"23","author":"Verso","year":"2005","journal-title":"J Clin Oncol"},{"issue":"18","key":"2019111902535688400_B37","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1200\/JCO.2005.10.192","article-title":"Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer","volume":"23","author":"Couban","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111902535688400_B38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/annonc\/mdj059","article-title":"Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial","volume":"17","author":"Karthaus","year":"2006","journal-title":"Ann Oncol"},{"issue":"9","key":"2019111902535688400_B39","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/j.1538-7836.2007.02660.x","article-title":"Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study","volume":"5","author":"Niers","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"9663","key":"2019111902535688400_B40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(09)60205-1","article-title":"Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial","volume":"373","author":"Young","year":"2009","journal-title":"Lancet"},{"issue":"12","key":"2019111902535688400_B41","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/annonc\/mdp235","article-title":"Early and short-term acenocumarine or dalteparin for the prevention of central vein catheter-related thrombosis in cancer patients: a randomized controlled study based on serial venographies","volume":"20","author":"De Cicco","year":"2009","journal-title":"Ann Oncol"},{"issue":"1","key":"2019111902535688400_B42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00280-013-2169-y","article-title":"Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study","volume":"72","author":"Lavau-Denes","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"2019111902535688400_B43","first-page":"CD006468","article-title":"Anticoagulation for patients with cancer and central venous catheters","volume-title":"Cochrane Database Syst Rev","author":"Akl","year":"2011"},{"issue":"2 suppl","key":"2019111902535688400_B44","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kahn","year":"2012","journal-title":"Chest"},{"issue":"10","key":"2019111902535688400_B45","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1200\/JCO.2012.45.5733","article-title":"Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline","volume":"31","author":"Schiffer","year":"2013","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111902535688400_B46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jth.12071","article-title":"International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer","volume":"11","author":"Debourdeau","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2019111902535688400_B47","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.6004\/jnccn.2013.0163","article-title":"Venous thromboembolic disease","volume":"11","author":"Streiff","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"issue":"suppl 5","key":"2019111902535688400_B48","doi-asserted-by":"crossref","first-page":"v152","DOI":"10.1093\/annonc\/mdv296","article-title":"Central venous access in oncology: ESMO Clinical Practice Guidelines","volume":"26","author":"Sousa","year":"2015","journal-title":"Ann Oncol"},{"issue":"2","key":"2019111902535688400_B49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"6","key":"2019111902535688400_B50","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1160\/TH12-05-0352","article-title":"Diagnosis and management of upper extremity deep-vein thrombosis in adults","volume":"108","author":"Grant","year":"2012","journal-title":"Thromb Haemost"},{"issue":"1","key":"2019111902535688400_B51","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1160\/TH07-08-0485","article-title":"A clinical prediction score for upper extremity deep venous thrombosis","volume":"99","author":"Constans","year":"2008","journal-title":"Thromb Haemost"},{"issue":"7","key":"2019111902535688400_B52","doi-asserted-by":"crossref","first-page":"451","DOI":"10.7326\/M13-2056","article-title":"Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study","volume":"160","author":"Kleinjan","year":"2014","journal-title":"Ann Intern Med"},{"issue":"4","key":"2019111902535688400_B53","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1538-7836.2010.03771.x","article-title":"Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review","volume":"8","author":"Di Nisio","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"2 suppl","key":"2019111902535688400_B54","doi-asserted-by":"crossref","first-page":"e351S","DOI":"10.1378\/chest.11-2299","article-title":"Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"issue":"8","key":"2019111902535688400_B55","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1538-7836.2007.02613.x","article-title":"A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study)","volume":"5","author":"Kovacs","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019111902535688400_B56","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.thromres.2014.11.020","article-title":"Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients","volume":"135","author":"Delluc","year":"2015","journal-title":"Thromb Res"},{"issue":"3","key":"2019111902535688400_B57","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jvsv.2015.03.002","article-title":"A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis","volume":"3","author":"Baumann Kreuziger","year":"2015","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"24","key":"2019111902535688400_B58","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N Engl J Med"},{"issue":"26","key":"2019111902535688400_B59","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N Engl J Med"},{"issue":"14","key":"2019111902535688400_B60","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"B\u00fcller","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"2019111902535688400_B61","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"issue":"15","key":"2019111902535688400_B62","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"B\u00fcller","year":"2013","journal-title":"N Engl J Med"},{"issue":"22","key":"2019111902535688400_B63","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1182\/blood.V128.22.531.531","article-title":"Treatment of venous thromboembolism in patients with hematological malignancies and severe thrombocytopenia: a retrospective cohort analysis","volume":"128","author":"Houghton","year":"2016","journal-title":"Blood"},{"issue":"9","key":"2019111902535688400_B64","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/jth.12338","article-title":"Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH","volume":"11","author":"Carrier","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019111902535688400_B65","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.thromres.2013.08.003","article-title":"Timing of recurrent venous thromboembolism early after the index event: a meta-analysis of randomized controlled trials","volume":"132","author":"Limone","year":"2013","journal-title":"Thromb Res"},{"issue":"6","key":"2019111902535688400_B66","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jvir.2010.02.021","article-title":"Pulmonary embolism from upper extremity deep vein thrombosis and the role of superior vena cava filters: a review of the literature","volume":"21","author":"Owens","year":"2010","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"2019111902535688400_B67","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1148\/radiology.211.1.r99ap4739","article-title":"Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry","volume":"211","author":"Mewissen","year":"1999","journal-title":"Radiology"},{"issue":"2","key":"2019111902535688400_B68","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/S2352-3026(15)00248-3","article-title":"Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial","volume":"3","author":"Haig","year":"2016","journal-title":"Lancet Haematol"},{"issue":"5","key":"2019111902535688400_B69","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00270-009-9655-y","article-title":"Catheter-directed thrombolysis for treatment of deep venous thrombosis in the upper extremities","volume":"32","author":"Vik","year":"2009","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"9","key":"2019111902535688400_B70","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00330-010-1771-1","article-title":"Catheter-directed thrombolytic therapy for thoracic deep vein thrombosis is safe and effective in selected patients with and without cancer","volume":"20","author":"Maleux","year":"2010","journal-title":"Eur Radiol"},{"issue":"1","key":"2019111902535688400_B71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/107602969900500106","article-title":"Regional thrombolysis with urokinase for central venous catheter-related thrombosis in patients undergoing high-dose chemotherapy with autologous blood stem cell rescue","volume":"5","author":"Schindler","year":"1999","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"2019111902535688400_B72","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11239-015-1318-z","article-title":"Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism","volume":"41","author":"Vedantham","year":"2016","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"2019111902535688400_B73","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.thromres.2005.05.029","article-title":"The post-thrombotic syndrome after upper extremity deep venous thrombosis in adults: a systematic review","volume":"117","author":"Elman","year":"2006","journal-title":"Thromb Res"},{"key":"2019111902535688400_B74","first-page":"1035","article-title":"Diagnostic Ultrasound","author":"Rumack","year":"2011","edition":"4th ed"},{"issue":"1","key":"2019111902535688400_B75","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1378\/chest.129.1.174","article-title":"Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians Task Force","volume":"129","author":"Guyatt","year":"2006","journal-title":"Chest"},{"issue":"7652","key":"2019111902535688400_B76","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Rating quality of evidence and strength of recommendations: going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"7650","key":"2019111902535688400_B77","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/20\/2727\/1400644\/blood693671.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/20\/2727\/1400644\/blood693671.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T22:11:50Z","timestamp":1601849510000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/20\/2727\/36112\/How-I-treat-central-venous-access-devicerelated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,18]]},"references-count":77,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2017,5,18]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-08-693671","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,18]]}}}